IMHA, or immune-mediated hemolytic anemia, is a condition where a cat’s immune system mistakenly attacks and destroys its own red blood cells. This destruction happens faster than the body can replace them, leading to a dangerous drop in red blood cell levels. A normal cat has a packed cell volume (PCV) between 25% and 45%, and cats with IMHA can fall well below that 25% threshold, sometimes critically so. It’s one of the more serious blood disorders in cats, but it is treatable when caught early.
How IMHA Destroys Red Blood Cells
In a healthy cat, the immune system leaves red blood cells alone. In IMHA, the body produces antibodies that latch onto the surface of normal red blood cells and mark them for destruction. Once tagged, those cells are broken down in several ways: the immune system can punch holes in them directly, recruit other immune cells to eat them, or flag them for removal by the liver and spleen. The result is the same. Red blood cells are eliminated far faster than the bone marrow can produce new ones, and the cat becomes progressively anemic.
When large numbers of red blood cells break apart, they release their contents into the bloodstream. This includes bilirubin, a yellow pigment that can build up and cause jaundice, the yellowing of the gums, skin, and whites of the eyes that many owners notice first.
Primary vs. Secondary IMHA
IMHA in cats falls into two categories. Primary (also called idiopathic) IMHA means the immune system attacks red blood cells for no identifiable reason. This form is diagnosed only after all other causes have been ruled out.
Secondary IMHA is more common in cats and occurs when something triggers the immune system to overreact. Known triggers include:
- Infections: Feline infectious peritonitis (FIP), feline leukemia virus (FeLV), and feline immunodeficiency virus (FIV) can all provoke immune-mediated destruction. There is a particularly strong link between a blood parasite called Mycoplasma haemofelis and IMHA in cats. Tick-borne organisms like Babesia and Cytauxzoon are also potential triggers.
- Inflammatory diseases: Pancreatitis, chronic kidney disease, and abscesses can set the stage for an immune overreaction that targets red blood cells.
- Cancer: Certain tumors, especially lymphoma, can trigger secondary IMHA.
Identifying the underlying cause matters because treating the trigger (for example, clearing a Mycoplasma infection with antibiotics) can sometimes resolve the anemia without long-term immune suppression.
Signs to Watch For
Cats with IMHA often deteriorate quickly, sometimes over just a few days. The hallmark signs all stem from the body not having enough red blood cells to carry oxygen:
- Pale or white gums: Healthy cat gums are pink. In anemic cats, they turn noticeably pale or even white.
- Lethargy and weakness: Cats may sleep more than usual, seem uninterested in food, or struggle to jump onto surfaces they normally reach easily.
- Rapid breathing or open-mouth breathing: With fewer red blood cells carrying oxygen, the body compensates by increasing the breathing rate.
- Yellowing of the gums or ears: Jaundice develops when broken red blood cells release bilirubin faster than the liver can process it.
- Dark or orange-brown urine: Breakdown products from destroyed red blood cells are filtered through the kidneys, discoloring the urine.
- Rapid heart rate: The heart pumps faster to circulate the reduced number of red blood cells more efficiently.
Some cats show only subtle signs at first, like eating a little less or being slightly quieter. Because anemia can progress rapidly in IMHA, even mild changes in energy level or appetite in a cat warrant attention.
How IMHA Is Diagnosed
Diagnosing IMHA requires proving three things: the cat is anemic, the anemia is caused by red blood cell destruction (not blood loss or production failure), and the immune system is responsible for that destruction.
The process starts with a complete blood count, which measures red blood cell levels and reveals whether the bone marrow is trying to compensate by releasing immature red blood cells into circulation. A blood smear examined under a microscope can show spherocytes, which are abnormally small, round red blood cells created when immune cells partially digest a normal red blood cell without fully destroying it. Spherocytes are highly suggestive of IMHA.
A saline agglutination test is one of the quickest in-clinic checks. A drop of blood is mixed with saline on a slide. If the red blood cells clump together in grape-like clusters rather than dispersing, it signals that antibodies are coating the cells and sticking them together. Cats naturally tend to form “stacks of coins” arrangements with their red blood cells (called rouleaux), which can look similar, so extra saline is added to distinguish true immune-driven clumping from this normal pattern.
The direct Coombs’ test (also called the direct antiglobulin test) is considered the gold standard. It detects antibodies or immune proteins physically attached to red blood cells. However, its sensitivity ranges from about 60% to 89%, meaning a negative result doesn’t completely rule out IMHA. A veterinarian will also test for infectious triggers, particularly Mycoplasma haemofelis, FeLV, and FIV, to determine whether the IMHA is primary or secondary.
Treatment and What to Expect
The immediate goal is to stop the immune system from destroying red blood cells. The cornerstone of treatment is immunosuppressive medication, typically a corticosteroid like prednisolone given at high doses initially. This suppresses the overactive immune response and gives the bone marrow a chance to replenish red blood cells.
In more severe cases, or when a cat doesn’t respond well to steroids alone, a second immunosuppressive drug is added. The two most commonly used options in cats are chlorambucil (a mild chemotherapy agent used at low doses for immune suppression) and cyclosporine. Your veterinarian will choose based on the severity of disease and how the cat tolerates initial treatment.
If the cat’s red blood cell levels are dangerously low, a blood transfusion may be needed to stabilize them while the medications take effect. This buys time but doesn’t treat the underlying problem, since transfused cells can also be targeted by the immune system.
When an infectious trigger like Mycoplasma haemofelis is identified, antibiotics are given alongside immunosuppressive therapy. In some of these cases, treating the infection alone is enough to resolve the anemia.
Long-Term Management and Tapering
Once a cat’s red blood cell levels stabilize and remain in the normal range, the immunosuppressive medications are gradually reduced over weeks to months. This tapering process is slow and deliberate because stopping too quickly risks a relapse. Frequent blood work, typically every one to two weeks during the initial phase and then at increasing intervals, tracks whether red blood cell counts stay stable as doses decrease.
Some cats can eventually come off medication entirely. Others relapse when doses drop below a certain point and need to stay on a low maintenance dose long-term. Side effects of prolonged steroid use in cats can include increased thirst and urination, weight gain, and a higher risk of developing diabetes, so the goal is always to find the lowest effective dose.
Cats on cyclosporine or chlorambucil need periodic blood work to monitor for effects on the liver, kidneys, and white blood cell counts. These rechecks are a normal part of managing IMHA and typically become less frequent over time if the cat remains stable.
Prognosis
IMHA is a serious diagnosis, but many cats respond well to treatment, especially when it’s caught before the anemia becomes life-threatening. Cats with secondary IMHA caused by a treatable infection tend to have a better outlook than those with primary IMHA, since removing the trigger can stop the immune attack entirely.
The most dangerous period is the first few days to weeks after diagnosis, when anemia is at its worst and the medications haven’t yet taken full effect. Cats that survive this initial phase and respond to immunosuppressive therapy have a reasonable chance of long-term survival. Relapses are possible, particularly during medication tapering, which is why ongoing monitoring is essential even when a cat seems to be doing well.